Phase 3 Clinical Trial: D-Methionine to Reduce Noise-Induced Hearing Loss (NIHL)

[Tinnitus Talk]

Tinnitus Talk submitted a new resource:

Phase 3 Clinical Trial: D-Methionine to Reduce Noise-Induced Hearing Loss (NIHL) (version 1.0) - To develop a safe, oral pharmacological agent to augment physical hearing protectors.

This prospective study is a randomized, double-blind, placebo-controlled Phase 3 clinical trial of oral D-met to reduce noise-induced hearing loss (NIHL) and tinnitus. The goal of the study is to develop a safe, oral pharmacological agent to augment physical hearing protectors for noise exposures that exceed the protective capabilities of ear plugs and/or muffs. The study population is a cohort of Drill Sergeant (DS) instructor trainees during and 22 days after their 11 day weapons training....

Read more about this resource...

 

[fabien]

Any news on this?

 

[Frédéric]

Just to recall the reference of the clinical trial:
https://clinicaltrials.gov/ct2/show/NCT02903355
Status: this study has been terminated. I did not find any results.
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)


But pay attention please, I also found another trial (with the double mention NIHL NIHL), which requires a new thread:
Phase 3 Clinical Trial: D-methionine to reduce Noise-Induced Hearing Loss (NIHL) (NIHL)
https://clinicaltrials.gov/ct2/show/study/NCT01345474
Status: this study is currently recruiting participants. I did not find any results.
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure).

See also this thread:
https://www.tinnitustalk.com/thread...e-interview-with-kathleen-campbell-phd.12771/